The pneumococcal conjugate vaccine—known as PCV—prevents around 30 percent of pneumonia, the most common cause of childhood ...

The decision to pause its investment in Britain came as AstraZeneca announced plans to spend $3.5bn (£2.7bn) expanding its US ...

Reading ‘Australia’s Pandemic Exceptionalism’ and this official response report is essential for anyone likely to have ...

This column, forecasting a Trump election win, last week expressed surprise so many news consumers remain loyal to media ...

The 868-page report of the official inquiry into Australia’s Covid-19 response, like the inquiry itself, is not fit for ...

AstraZeneca shares on Tuesday recorded their worst day since March 2020 after a report that dozens of the drugmaker's senior ...

Controversy followed close on the heels of a recent study on the long-term safety of Covaxin, the Covid-19 vaccine developed by Bharat Biotech in collaboration ...

AstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, but AstraZeneca stock slipped amid a criminal probe in China.

Chiropractors for RFK —Three appeals in a pod —The FDA shortage saga —The ghost of elections past And more! Join the conversation here.

A long negative candle was formed on the daily chart after the upside bounce of the last two sessions. The crucial overhead ...